BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$2.81B |
| 2 |
Linde
LIN
|
+$2.35B |
| 3 |
Chevron
CVX
|
+$1.53B |
| 4 |
Pfizer
PFE
|
+$1.38B |
| 5 |
UnitedHealth
UNH
|
+$1.35B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$3.75B |
| 2 |
CERN
Cerner Corp
CERN
|
+$2.23B |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$1.1B |
| 4 |
Baidu
BIDU
|
+$1.07B |
| 5 |
NXP Semiconductors
NXPI
|
+$998M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.27% |
| 2 | Healthcare | 15.23% |
| 3 | Financials | 12.33% |
| 4 | Consumer Discretionary | 9.59% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTHY
4001
First Trust High Yield Opportunities 2027 Term Fund
FTHY
$498M
| $2.12M | ﹤0.01% |
+146,000
| New | +$2.3M |
|
4002
Goldgroup Mining Inc.
GORO
$164M
| $2.12M | ﹤0.01% |
1,300,022
+26,118
| +2% | +$51.3K |
|
|
IMDX
4003
Insight Molecular Diagnostics
IMDX
$162M
| $2.11M | ﹤0.01% |
117,171
-129,511
| -53% | -$2.95M |
|
|
VIRX
4004
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $2.1M | ﹤0.01% |
542,431
-1,770,477
| -77% | -$5.04M |
|
|
SMLR
4005
DELISTED
Semler Scientific
SMLR
| $2.1M | ﹤0.01% |
74,601
+10,769
| +17% | +$385K |
|
4006
Cue Biopharma
CUE
$113M
| $2.07M | ﹤0.01% |
27,731
-51,645
| -65% | -$6.04M |
|
4007
iShares Paris-Aligned Climate Optimized MSCI USA ETF
PABU
$2.48B
| $2.07M | ﹤0.01% |
+50,000
| New | +$2.19M |
|
4008
INmune Bio
INMB
$49.2M
| $2.07M | ﹤0.01% |
234,120
+2,121
| +0.9% | +$15.8K |
|
4009
Plains All American Pipeline
PAA
$17.1B
| $2.07M | ﹤0.01% |
210,577
+7,492
| +4% | +$81.2K |
|
4010
EuroDry
EDRY
$72.8M
| $2.07M | ﹤0.01% |
114,184
-65,816
| -37% | -$1.98M |
|
|
INZY
4011
DELISTED
Inozyme Pharma
INZY
| $2.05M | ﹤0.01% |
430,520
-447,880
| -51% | -$1.95M |
|
4012
Barnes & Noble Education
BNED
$447M
| $2.05M | ﹤0.01% |
6,981
-52,584
| -88% | -$15.3M |
|
|
KG
4013
Kestrel Group
KG
$66.7M
| $2.05M | ﹤0.01% |
52,697
-166,153
| -76% | -$7.43M |
|
|
LNAI
4014
Lunai Bioworks
LNAI
$10.8M
| $2.04M | ﹤0.01% |
13,206
+10,705
| +428% | +$4.9M |
|
4015
Priority Technology Holdings
PRTH
$549M
| $2.03M | ﹤0.01% |
615,062
+139,450
| +29% | +$685K |
|
4016
B2Gold
BTG
$5.13B
| $2.03M | ﹤0.01% |
598,315
-38,444
| -6% | -$161K |
|
|
IMOS
4017
ChipMOS TECHNOLOGIES
IMOS
$1.68B
| $2.02M | ﹤0.01% |
80,933
-17,265
| -18% | -$561K |
|
4018
Dimensional US Core Equity 2 ETF
DFAC
$48.5B
| $2.01M | ﹤0.01% |
86,256
| – | – |
|
4019
Bausch Health
BHC
$2.62B
| $1.98M | ﹤0.01% |
237,163
+54,124
| +30% | +$757K |
|
|
BOXD
4020
DELISTED
Boxed, Inc.
BOXD
| $1.98M | ﹤0.01% |
1,068,508
+452,263
| +73% | +$3.49M |
|
|
TRQ
4021
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $1.97M | ﹤0.01% |
73,727
+10,205
| +16% | +$289K |
|
4022
BioAtla
BCAB
$5.41M
| $1.96M | ﹤0.01% |
13,752
-18,133
| -57% | -$2.89M |
|
|
MMP
4023
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $1.95M | ﹤0.01% |
40,859
+1,154
| +3% | +$57.6K |
|
4024
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.7B
| $1.95M | ﹤0.01% |
28,190
-429
| -1% | -$30.3K |
|
4025
Sibanye-Stillwater
SBSW
$6.33B
| $1.95M | ﹤0.01% |
195,584
-16,658
| -8% | -$218K |
|
Similar funds
BlackRock's Q2 2022 Portfolio in Review
As of Q2 2022, BlackRock held 6,138 positions worth $3.12T, down 16% from $3.71T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2022 filing shows 278 new, 2,738 increased, 2,355 reduced and 221 closed positions. Its largest new stake was Aspen Technology Inc: 2,824,931 shares worth $519M. The largest sale was AT&T, an estimated $3.75B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2022 buy was Aspen Technology Inc: 2,824,931 shares worth $519M.
- BlackRock added most to Warner Bros in Q2 2022, an estimated $2.81B increase.
- BlackRock's biggest Q2 2022 reduction was AT&T, cutting an estimated $3.75B.
- BlackRock fully exited Cerner Corp in Q2 2022, selling an estimated $2.23B.
- BlackRock's ten largest holdings make up 19% of its $3.12T portfolio in Q2 2022.
- BlackRock opened 278 new positions and closed 221 in Q2 2022.
- BlackRock's portfolio value fell 16% quarter-over-quarter to $3.12T.
Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.